In addition to comments on the Cigna-Catamaran deal, we also cover:
- How PBMs influence the healthcare system
- Why the current PBM business model will needs to evolve
- How drugmakers will need to work with payers and PBMs
If you don't see any audio controls above, click here to listen to the podcast.